from the desk of Dr. Terry F Allen

Skip navigation

Member Login  |  Contact Us  |  Sign Up

802-877-8330

Emergent (EBS) Rallies as CEO Discusses Plans of Coronavirus Vaccine Development

This week we are looking at another of the Investor’s Business Daily (IBD) Top 50 List companies.  We use this list in one of our options portfolios to spot outperforming stocks and place option spreads that take advantage of the momentum.

A few biotech companies are rallying as investors are encouraged by the prospect of a Coronavirus vaccine, and EBS is one of them. The following two articles discuss the matter in detail –  Emergent (EBS) Begins Development of Treatments for COVID-19 and Emergent BioSolutions CEO Talks Coronavirus Vaccine Development.

Technicals

EBS is an outperformer and posted its highest weekly close since 2018 in the past week. In the process, the stock has overtaken a major horizontal resistance level at $66 that proved to be a hurdle on a few attempts between 2019 and 2020. On a weekly chart, the stock has posted a strong upside candle that erases several weeks of declines which can be seen as a bullish signal. Further, the stock is in a clear uptrend since bottoming out in late August and the recent upward momentum suggests the bullish trend remains intact.

EBS Chart March 2020 Covid-19 response

EBS Chart March 2020

If you agree there’s further upside ahead for EBS, consider this trade which is a bet that the stock will continue to advance over the next five weeks, at least a little bit.

Buy To Open EBS 17APR20 65 Puts (EBS200417P65)
Sell To Open EBS 17APR20 70 Puts (EBS200417P70) for a credit of $1.78 (selling a vertical)

This price was $0.02 less than the mid-point of the option spread when EBS was trading near $69.  Unless the stock rallies quickly from here, you should be able to get close to this amount.

Your commission on this trade will only be $1.30 per spread.  Each contract would then yield $176.70 and your broker would charge a $500 maintenance fee, making your investment $323.30 ($500 – $176.70).  If EBS closes at any price above $70 on April 17, both options would expire worthless, and your return on the spread would be 55% (627% annualized).

Changes to Investor’s Business Daily (IBD) Top 50 This Week:

IBD Underlying Updates March 14, 2020

IBD Underlying Updates March 14, 2020

We have found that the Investor’s Business Daily Top 50 List has been a reliable source of stocks that are likely to move higher in the short run.  Recent additions to the list might be particularly good choices for this strategy, and deletions might be good indicators for exiting a position that you might already have on that stock.

As with all investments, you should only make option trades with money that you can truly afford to lose.

Happy trading,

Terry

Tags: , , , , , , , , , , , , , , , , , ,

Making 36%

Making 36% — A Duffer's Guide to Breaking Par in the Market Every Year in Good Years and Bad

This book may not improve your golf game, but it might change your financial situation so that you will have more time for the greens and fairways (and sometimes the woods).

Learn why Dr. Allen believes that the 10K Strategy is less risky than owning stocks or mutual funds, and why it is especially appropriate for your IRA.

Order Now

Success Stories

I have been trading the equity markets with many different strategies for over 40 years. Terry Allen's strategies have been the most consistent money makers for me. I used them during the 2008 melt-down, to earn over 50% annualized return, while all my neighbors were crying about their losses.

~ John Collins